All reports

All KCE reports are available in Dutch, French and English under several formats. Form and language of the reports

Publication year:
General domain:
Specific domain:

  1. [Hadrontherapy]

    KCE Reports 67 (2007)

    https://kce.fgov.be/en/publication/report/hadrontherapy

  2. [Prostate-specific-antigen (PSA) for the screening of prostate cancer]

    KCE Reports 31 (2006)

    https://kce.fgov.be/en/publication/report/prostate-specific-antigen-psa-for-the-screening-of-prostate-cancer

  3. [Rapid assessment of a selection of new treatments for prostate cancer and benign prostate hypertrophy]

    KCE Reports 89 (2008)

    https://kce.fgov.be/en/publication/report/rapid-assessment-of-a-selection-of-new-treatments-for-prostate-cancer-and-benign-

  4. [Screening for Colorectal Cancer : current evidence and budget impact for Belgium.]

    KCE Reports 45 (2006)

    https://kce.fgov.be/en/publication/report/screening-for-colorectal-cancer-current-evidence-and-budget-impact-for-belgium

  5. Autologous breast reconstruction techniques after mammary resection: time measurements for a potential reevaluation of the surgeon fee

    KCE Reports 251 (2015)

    https://kce.fgov.be/en/publication/report/autologous-breast-reconstruction-techniques-after-mammary-resection-time-measurem
  6. R285

    Bevacizumab in the treatment of ovarian cancer

    KCE Reports 285 (2017)

    https://kce.fgov.be/en/publication/report/bevacizumab-in-the-treatment-of-ovarian-cancer

  7. Cervical cancer screening program and Human Papillomavirus (HPV) testing, part II: Update on HPV primary screening

    KCE Reports 238 (2015)

    https://kce.fgov.be/en/publication/report/cervical-cancer-screening-program-and-human-papillomavirus-hpv-testing-part-ii-up

  8. Do innovative medicines against cancer always have a real added value?

    KCE Reports 343 (2021)  

    https://kce.fgov.be/en/do-innovative-medicines-against-cancer-always-have-a-real-added-value

  9. Gene expression profiling and immunohistochemistry tests for personalised management of adjuvant chemotherapy decisions in early breast cancer – a Rapid Assessment

    KCE Reports 237 (2015)

    https://kce.fgov.be/en/publication/report/gene-expression-profiling-and-immunohistochemistry-tests-for-personalised-managem

  10. Hadron therapy in children – an update of the scientific evidence for 15 paediatric cancers

    KCE Reports 235 (2015)

    https://kce.fgov.be/en/publication/report/hadron-therapy-in-children-%E2%80%93-an-update-of-the-scientific-evidence-for-15-paediatr

  11. HPV Vaccination for the Prevention of Cervical Cancer in Belgium: Health Technology Assessment

    KCE Reports 64 (2007)

    https://kce.fgov.be/en/publication/report/hpv-vaccination-for-the-prevention-of-cervical-cancer-in-belgium-health-technolog

  12. Innovative radiotherapy techniques: a multicentre time-driven activity-based costing study

    KCE Reports 198 (2013)

    https://kce.fgov.be/en/innovative-radiotherapy-techniques-a-multicentre-time-driven-activity-based-costing-study
  13. Illustration report 298

    MammaPrint® test for personalised management of adjuvant chemotherapy decisions in early breast cancer

    KCE Report 298 (2018) Breast cancer is the most commonly diagnosed cancer in women in Belgium and throughout the world. Provided this cancer is in the early stage, treatment is essentially locoregional, that is, via surgery alone or combined with radiation therapy. In theory, this treatment is enough to eradicate the tumour since it is still limited. However, it is known that about 30% of patients treated in this way are at risk of developing remote metastases, because metastatic cancerous cells are already present but undetectable at the time of diagnosis.

    https://kce.fgov.be/en/mammaprint%C2%AE-test-for-personalised-management-of-adjuvant-chemotherapy-decisions-in-early-breast

  14. Next generation sequencing gene panels for targeted therapy in oncology and haemato-oncology

    KCE Reports 240 (2015)

    https://kce.fgov.be/en/publication/report/next-generation-sequencing-gene-panels-for-targeted-therapy-in-oncology-and-haema
  15. Scaner with a nurse

    Proton beam therapy in adults

    KCE Reports 307 (2019) Proton therapy is a radiation therapy technique which allows large doses of radiation to be delivered to cancerous tumours without (excessively) “overflowing” to adjacent tissues. There has been much talk of this technique in recent years, since two projects by proton therapy centres are ongoing in Belgium, one in Louvain and the other in Charleroi.

    https://kce.fgov.be/en/proton-beam-therapy-in-adults

  16. Trastuzumab in Early Stage Breast Cancer

    KCE Reports 34 (2006) 30 June (2nd edition; 22 June 2006, 1st edition)

    https://kce.fgov.be/en/publication/report/trastuzumab-in-early-stage-breast-cancer